Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago
- PMID: 16493002
- DOI: 10.1182/blood-2005-12-5158
Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago
Abstract
Prothrombin 20210G>A and factor V Leiden are common prothrombotic mutations in whites for which founder effects have been established. In this study, we analyzed the frequencies of 5 single nucleotide polymorphisms (SNPs) and 9 microsatellites flanking the prothrombin gene (F2) in 88 homozygotes for 20210A and 66 homozygotes for 20210G. For estimating the age of the prothrombin 20210G>A mutation, we used the DMLE+2.0 program, which analyzed linkage disequilibria between the mutation and the multiple markers that had been assessed. This analysis yielded an age estimate of 23,720 years (95% credible set, 19,080-31,340 years). A similar analysis by the DMLE+2.0 program was performed on 5 SNPs from previously studied homozygotes for factor V Leiden and controls that yielded an age estimate of 21,340 years (95% credible set, 16,880-29,480 years). The occurrence of the 2 mutations in whites toward the end of the last glaciation and their presently wide distribution in whites suggest selective evolutionary advantages for which some evidence was reported (diminished blood loss) or is controversial (protection against infections).
Similar articles
-
Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.Blood. 2003 Apr 15;101(8):3037-41. doi: 10.1182/blood-2002-09-2888. Epub 2002 Dec 12. Blood. 2003. PMID: 12480694
-
Effects of MTHFR c.677C>T, F2 c.20210G>A and F5 Leiden Polymorphisms in Gastroschisis.J Invest Surg. 2016;29(2):88-92. doi: 10.3109/08941939.2015.1077908. Epub 2015 Sep 16. J Invest Surg. 2016. PMID: 26375922
-
Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.Circ Res. 2019 Aug 16;125(5):523-534. doi: 10.1161/CIRCRESAHA.119.315037. Epub 2019 Jul 17. Circ Res. 2019. PMID: 31314700
-
Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics.Mol Genet Metab. 2005 Sep-Oct;86(1-2):91-9. doi: 10.1016/j.ymgme.2005.04.002. Epub 2005 Sep 26. Mol Genet Metab. 2005. PMID: 16185908 Review.
-
[From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].Ned Tijdschr Geneeskd. 2001 Sep 22;145(38):1843-5. Ned Tijdschr Geneeskd. 2001. PMID: 11593787 Review. Dutch.
Cited by
-
The hemostatic balance revisited through the lessons of mankind evolution.Intern Emerg Med. 2008 Mar;3(1):3-8. doi: 10.1007/s11739-008-0100-z. Epub 2008 Feb 19. Intern Emerg Med. 2008. PMID: 18283529 Review.
-
Application of Human Genetics to Prioritize Coagulation Cascade Protein Targets for Ischemic Stroke Prevention.Stroke. 2025 Jun;56(6):1542-1553. doi: 10.1161/STROKEAHA.124.049808. Epub 2025 Apr 6. Stroke. 2025. PMID: 40188416 Free PMC article.
-
Framing postpartum hemorrhage as a consequence of human placental biology: an evolutionary and comparative perspective.Am Anthropol. 2011;113(3):417-30. doi: 10.1111/j.1548-1433.2011.01351.x. Am Anthropol. 2011. PMID: 21909154 Free PMC article.
-
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.Eur J Hum Genet. 2014 Jul;22(7):923-9. doi: 10.1038/ejhg.2012.309. Epub 2013 Jan 30. Eur J Hum Genet. 2014. PMID: 23361220 Free PMC article.
-
The distribution of Factor V Leiden mutation.J Thromb Thrombolysis. 2013 Oct;36(3):341-2. doi: 10.1007/s11239-012-0848-x. J Thromb Thrombolysis. 2013. PMID: 23184485 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous